125 related articles for article (PubMed ID: 2731595)
1. Radiolabelling of human platelets with 99mTc-HMPAO.
Vorne M; Honkanen T; Karppinen K; Röning M; Sakki S
Eur J Haematol; 1989 May; 42(5):487-91. PubMed ID: 2731595
[TBL] [Abstract][Full Text] [Related]
2. Tc-99m-HMPAO labelled human platelets: in vitro and in vivo results.
Becker W; Borst U; Krahe T; Börner W
Eur J Nucl Med; 1989; 15(6):296-301. PubMed ID: 2767079
[TBL] [Abstract][Full Text] [Related]
3. Investigations to determine the optimum conditions for radiolabelling human platelets with 99Tcm-hexamethyl propylene amine oxime (99Tcm-HM-PAO).
Danpure HJ; Osman S
Nucl Med Commun; 1988 Apr; 9(4):267-72. PubMed ID: 3399223
[TBL] [Abstract][Full Text] [Related]
4. 99Tcm hexamethylpropyleneamineoxime (HMPAO) as a platelet label: evaluation of labelling parameters and first in vivo results.
Becker W; Börner W; Borst U
Nucl Med Commun; 1988 Oct; 9(10):831-42. PubMed ID: 3211441
[TBL] [Abstract][Full Text] [Related]
5. The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm-hexamethylpropyleneamine oxime.
Danpure HJ; Osman S; Carroll MJ
Nucl Med Commun; 1988 Jun; 9(6):465-75. PubMed ID: 3412734
[TBL] [Abstract][Full Text] [Related]
6. Venous thrombosis: a controlled study on the performance of scintigraphy with 99Tcm-HMPAO-labelled platelets versus venography.
Honkanen T; Jauhola S; Karppinen K; Paul R; Sakki S; Vorne M
Nucl Med Commun; 1992 Feb; 13(2):88-94. PubMed ID: 1436902
[TBL] [Abstract][Full Text] [Related]
7. Thrombus imaging with 99mTc-HMPAO-labeled platelets and 111In-labeled monoclonal antifibrin antibodies.
Vorne MS; Honkanen TT; Lantto TJ; Laitinen RO; Karppinen KJ; Jauhola SV
Acta Radiol; 1993 Jan; 34(1):59-63. PubMed ID: 8427751
[TBL] [Abstract][Full Text] [Related]
8. Labelling of leukocytes with 99mTc-HMPAO for scintigraphy of inflammatory lesions and abscesses.
Vanlić-Razumenić N; Pujić N; Dedović N; Kostić K; Nastić-Mirić D
Int J Rad Appl Instrum B; 1992 Apr; 19(3):251-6. PubMed ID: 1629013
[TBL] [Abstract][Full Text] [Related]
9. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
[TBL] [Abstract][Full Text] [Related]
10. A new 99mTc labelling method for leucocytes: in vitro and in vivo comparison with 99mTc-HMPAO.
Welling M; Feitsma HI; Blok D; Calame W; Ensing GJ; Goedemans W; Pauwels EK
Q J Nucl Med; 1995 Jun; 39(2):89-98. PubMed ID: 8574810
[TBL] [Abstract][Full Text] [Related]
11. Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease.
Giaffer MH; Tindale WB; Holdsworth D
Eur J Gastroenterol Hepatol; 1996 Dec; 8(12):1195-200. PubMed ID: 8980940
[TBL] [Abstract][Full Text] [Related]
12. Procedure for red blood cell labelling with 99mTc-HMPAO. Methodology and quality control.
Bassa P; García Garzón JR; Piera C; Pavía A; Minoves M; Moragas M; Pavía J; Lomeña F; Setoain J
Nucl Med Biol; 1994 Oct; 21(7):963-7. PubMed ID: 9234351
[TBL] [Abstract][Full Text] [Related]
13. 111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content.
Blocklet D; Toungouz M; Kiss R; Lambermont M; Velu T; Duriau D; Goldman M; Goldman S
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):440-7. PubMed ID: 12722741
[TBL] [Abstract][Full Text] [Related]
14. [99mTc-HMPAO labeling of leukocytes and thrombocytes. Characteristics and diagnostic consequences].
Becker W; Börner W
Rofo; 1988 Jan; 148(1):69-74. PubMed ID: 2829311
[TBL] [Abstract][Full Text] [Related]
15. Tc-99m-HMPAO: a new platelet labelling compound?
Becker W; Börner W; Borst U; Kromer EP; Gruner KR
Eur J Nucl Med; 1987; 13(5):267-8. PubMed ID: 3665973
[No Abstract] [Full Text] [Related]
16. [Comparison of 99m Tc-HMPAO-labeled leukocytes and 99m Tc-nanocolloid in osteomyelitis].
Hotze A; Bockisch A; Rüther M; Biersack HJ
Nuklearmedizin; 1988 Mar; 27(2):63-5. PubMed ID: 3368340
[TBL] [Abstract][Full Text] [Related]
17. Thrombocytes labelled with 99mTc-HMPAO in vitro studies and preliminary clinical experience.
Hardeman MR
Prog Clin Biol Res; 1990; 355():49-54. PubMed ID: 2149183
[No Abstract] [Full Text] [Related]
18. Abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondylarthropathies without clinical evidence of inflammatory bowel disease.
Alonso JC; Lopez-Longo FJ; Lampreave JL; González CM; Vegazo O; Carreño L; Almoguera I
Eur J Nucl Med; 1996 Mar; 23(3):243-6. PubMed ID: 8599954
[TBL] [Abstract][Full Text] [Related]
19. An in vitro study to compare 99mTc-stannous colloids and 99mTc-HMPAO for labelling human leukocytes.
Capriotti G; D'Alessandria C; Garin E; Weber E; Devillers A; Lehmann K; Corsetti F; Lecloirec J; Meller J; Becker W; Moisan A; Signore A
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):229-36. PubMed ID: 15499297
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: diagnostic and clinical relevance.
Sciarretta G; Furno A; Mazzoni M; Basile C; Malaguti P
Gut; 1993 Oct; 34(10):1364-9. PubMed ID: 8244102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
